Eximia Clinical Research

Raleigh, North Carolina 27607

0 studies enrolling now · 2 studies all time

What they study most

Epstein-Barr Virus Infection, Seasonal Influenza

Studies at this site

• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants — Running, not enrolling
• A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age — Completed